These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report. Rashid S; Fields AR; Baumrucker SJ Am J Hosp Palliat Care; 2018 Mar; 35(3):511-513. PubMed ID: 28641445 [TBL] [Abstract][Full Text] [Related]
24. Active upper-limb movement can be improved in hemiplegic patients by botulinum toxin injection. Yelnik A J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):357. PubMed ID: 20360163 [No Abstract] [Full Text] [Related]
25. Botulinum toxin physiology in focal hand and cranial dystonia. Karp BI Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323 [TBL] [Abstract][Full Text] [Related]
26. Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis. Gonçalves MR; Barbosa ER; Zambon AA; Marchiori PE Arq Neuropsiquiatr; 1999 Sep; 57(3A):683-5. PubMed ID: 10667297 [TBL] [Abstract][Full Text] [Related]
27. Recurrent TMJ Dislocation Managed with Botulinum Toxin Type A Injections in a Pediatric Patient. Stark TR; Perez CV; Okeson JP Pediatr Dent; 2015; 37(1):65-9. PubMed ID: 25685976 [TBL] [Abstract][Full Text] [Related]
28. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease. Maiola R; Ramirez Gómez CC; Micheli F J Neurol Sci; 2016 Nov; 370():256-257. PubMed ID: 27772770 [No Abstract] [Full Text] [Related]
29. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Rollnik JD; Matzke M; Wohlfarth K; Dengler R; Bigalke H Eur Neurol; 2000; 43(1):9-12. PubMed ID: 10601802 [TBL] [Abstract][Full Text] [Related]
30. [Using botulinum toxin (Botox) for treatment of patients with postroke spasticity]. Khat'kova SE Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):87-90. PubMed ID: 19685598 [No Abstract] [Full Text] [Related]
34. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy? Bradley LJ; Huntley JS Arch Dis Child; 2014 Apr; 99(4):392-4. PubMed ID: 24626322 [No Abstract] [Full Text] [Related]
35. Sonography-guided injection of botulinum toxin A in children with cerebral palsy. Berweck S; Feldkamp A; Francke A; Nehles J; Schwerin A; Heinen F Neuropediatrics; 2002 Aug; 33(4):221-3. PubMed ID: 12368994 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin A for patients with orofacial dystonia: prospective, observational, single-centre study. Ruiz-de-León-Hernández G; Díaz-Sánchez RM; Torres-Lagares D; Hernández-Pacheco E; González-Martín M; Serrera-Figallo MA Int J Oral Maxillofac Surg; 2018 Mar; 47(3):386-391. PubMed ID: 29208327 [TBL] [Abstract][Full Text] [Related]
37. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin. Bakke M; Baram S; Dalager T; Biernat HB; Møller E J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806 [TBL] [Abstract][Full Text] [Related]
38. [Treatment with botulinum toxin in neurologic pediatrics]. Justus N; Lee SH; Berweck S; Heinen F Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921 [No Abstract] [Full Text] [Related]